Advertisement

Search Results

Advertisement



Your search for Kenneth L. Kehl, MD matches 5 pages

Showing 1 - 5


lung cancer

Guideline-Concordant Surgery and Adjuvant Chemotherapy for Early-Stage NSCLC

In a retrospective cohort study reported in JAMA Oncology, Kenneth L. Kehl, MD, MPH, and colleagues found that only a slight majority of patients with early-stage non–small cell lung cancer (NSCLC) who were enrolled in a U.S. screening study (ALCHEMIST) received guideline-recommended adequate lymph ...

health-care policy

Most Federal Exchange Plans Under Affordable Care Act Do Not Contain NCI-Designated Cancer Center

In a study reported in the Journal of Clinical Oncology, Kehl et al found that most federal exchange networks under the Affordable Care Act contain a Commission on Cancer–accredited hospital, but less than half contain a National Cancer Institute (NCI)-designated cancer center. Study Details ...

issues in oncology

Effects of the Global Economic Crisis on Cancer Care

The global economic crisis beginning in 2008 was associated with substantial public health effects, especially with respect to mental health.1–3 Nevertheless, there is also evidence of a paradoxical association between recessions and reduced all-cause mortality, in part because of reductions in...

colorectal cancer
lung cancer

Tumor Board Participation Associated With Improved Survival in Stage IV Lung and Colorectal Cancers

A large, population-based, observational study suggests that participation in weekly tumor boards can improve outcomes in oncologic care. Specifically, oncologist participation in weekly tumor board meetings was associated with improved survival in patients with stage IV small cell lung cancer and...

issues in oncology

Oncologist Participation in Tumor Board Meetings May Be Associated With Improved Outcomes for Patients With Lung or Colorectal Cancers

A new population-based study of close to 5,000 patients and 1,600 oncologists found that physician participation in weekly tumor board meetings was associated with improved survival for patients with stage IV colorectal cancer and stage IV/extensive-stage small cell lung cancer, but not other...

Advertisement

Advertisement




Advertisement